NCT06756308 2025-12-23A Study of Enasidenib in People With T-Cell LymphomaMemorial Sloan Kettering Cancer CenterPhase 2 Recruiting25 enrolled
NCT03259503 2025-11-10Olaparib and High-Dose Chemotherapy in Treating Patients With Relapsed or Refractory Lymphomas Undergoing Stem Cell TransplantM.D. Anderson Cancer CenterPhase 1 Completed50 enrolled